Skip to content

Hummingbird TTS Ear Tube Delivery Study

Continued Evaluation of the Preceptis Medical, Inc. Tympanostomy Ear Tube Introducer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02165384
Enrollment
199
Registered
2014-06-17
Start date
2014-01-31
Completion date
2018-03-01
Last updated
2019-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis Media

Keywords

tympanostomy, myringotomy, otitis media, ear tubes, ear infection

Brief summary

The purpose of this study is to determine if the Hummingbird ear tube delivery system is a safe and effective way to put ear tubes in place.

Detailed description

The objective of this study is to evaluate the safety and performance of the TTI device for the placement of ear tubes in patients undergoing a tympanostomy tube placement procedure.The trial will be a multi-site, prospective, treatment only study of the Preceptis ear tube introducer . Patients will already have a scheduled tympanostomy procedure. Enrollment in the study at each site will begin after receipt of Institutional Review Board (IRB) approval. Patients will be considered enrolled at the time the informed consent document is signed. A maximum of two hundred fifty (250) subjects will be included in the study at up to 5 sites.

Interventions

DEVICEEar tube placement with the Hummingbird TTS

Using the Hummingbird TTS to make a myringotomy and deliver a tympanostomy tube across the tympanic membrane with one pass.

Sponsors

Preceptis Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to No maximum
Healthy volunteers
No

Inclusion criteria

1. Scheduled to undergo tympanostomy tube insertion. 2. At least 6 months old. 3. Subject is able and willing to comply with follow-up requirements. 4. Signed Informed Consent, Parental Consent Form, or Child Assent Form as applicable.

Exclusion criteria

1. Any condition that in the opinion of the investigator may place the subject at greater risk (e.g., pregnancy) 2. Significantly atrophic tympanic membrane. 3. Significantly atelectatic tympanic membrane. For example, the tympanic membrane is in contact with the promontory of the cochlea. 4. Anatomy precludes sufficient visualization and access to the tympanic membrane.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Ears in Which an Ear Tube Was Successfully Delivered Across the Tympanic Membraneintra operativeSuccess will be determined at the end of each ear tube procedure, by whether or not the TTS was used during the tympanostomy procedure to make an incision in the tympanic membrane and deploy an ear tube. Data may be presented when enrollment has been completed and all pre-operative and procedure data are analyzed.
Number of Participants With Intra-operative Adverse EventsIntra-operativeAny intra-operative adverse events, anticipated or unanticipated

Countries

United States

Participant flow

Participants by arm

ArmCount
Hummingbird TTS
Treatment only surgical instrument study
199
Total199

Baseline characteristics

CharacteristicHummingbird TTS
Age, Customized20 months
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
199 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
199 participants
Sex: Female, Male
Female
NA Participants
Sex: Female, Male
Male
NA Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 199
other
Total, other adverse events
0 / 199
serious
Total, serious adverse events
0 / 199

Outcome results

Primary

Number of Participants With Intra-operative Adverse Events

Any intra-operative adverse events, anticipated or unanticipated

Time frame: Intra-operative

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Hummingbird TTSNumber of Participants With Intra-operative Adverse Events0 Participants
Primary

Percentage of Ears in Which an Ear Tube Was Successfully Delivered Across the Tympanic Membrane

Success will be determined at the end of each ear tube procedure, by whether or not the TTS was used during the tympanostomy procedure to make an incision in the tympanic membrane and deploy an ear tube. Data may be presented when enrollment has been completed and all pre-operative and procedure data are analyzed.

Time frame: intra operative

Population: 393 ears in 199 patients received ear tube placement from the Hummingbird device.

ArmMeasureValue (COUNT_OF_UNITS)
Hummingbird TTSPercentage of Ears in Which an Ear Tube Was Successfully Delivered Across the Tympanic Membrane393 Ears

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026